Abstract
A double-blind, paired-lesion comparison of fluocinonide 0·05% in a fatty alcohol propylene glycol base and betamethasone-17-valerate 0·1% cream in the treatment of patients with eczema or psoriasis, is described. The fluocinonide preparation, ‘Metosyn’, was significantly superior to betamethasone-17-valerate in the treatment of patients with eczema. Both topical steroids were equally effective in the treatment of psoriasis. The advantage of fluocinonide over betamethasone-17-valerate was seen mainly in those patients who had been treated with betamethasone-17-valerate preparations before the start of the investigation. Tolerance was equally good with both preparations.
Get full access to this article
View all access options for this article.
